Trial Profile
Low- versus high-dose thalidomide in patients with advanced multiple myeloma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Mar 2012
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 01 Mar 2012 Results published in the European Journal of Haematology.
- 05 Nov 2010 New trial record.